• No se han encontrado resultados

Efficacy of oral L ornithine L aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy

N/A
N/A
Protected

Academic year: 2020

Share "Efficacy of oral L ornithine L aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy"

Copied!
5
0
0

Texto completo

Loading

Figure

Figure 1. Urea cycle.
Figure 2. LOLA enhan-

Referencias

Documento similar

For a short explanation of why the committee made these recommendations and how they might affect practice, see the rationale and impact section on identifying children and young

 The expansionary monetary policy measures have had a negative impact on net interest margins both via the reduction in interest rates and –less powerfully- the flattening of the

Jointly estimate this entry game with several outcome equations (fees/rates, credit limits) for bank accounts, credit cards and lines of credit. Use simulation methods to

Changes in serum IL-15 levels at 4 and 8 weeks as compared with baseline values were directly associated with changes in body weight, BMI, fat-free mass, and muscle mass

Restless legs syndrome in patients with high serum ferritin and normal iron

Circulating interleukin 6 and albumin, and infliximab levels are good predictors of recovering efficacy after dose escalation infliximab therapy in patients with loss of response

In agreement with the observed changes in hepatic SREBP-1c expression in liver, central leptin blunted the up- regulation of the mRNA levels of ACC, FAS, and SCD-1 elicited by the

We know that patients with kidney disease have elevated serum levels of BPA and that some of the effects of BPA in laboratory ani- mals also appear in uraemic patients on